
|Podcasts|November 3, 2017
Alzheimer Disease: New Drugs in the Offing?
Author(s)Howard Fillit, MD
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
Advertisement
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
Here, Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
3
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
4
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
5










